Mivacurium and succinylcholine (Adverse Reactions)

Pseudocholinesterase deficiency is a rare enzymatic alteration that leads to an increased risk of adverse effects from certain muscle relaxants, such as mivacurium and succinylcholine, used during general anesthesia in certain countries.

Mivacurium is a short-acting, non-depolarizing neuromuscular blocking agent used as an adjunct in general anesthesia to relax skeletal muscles. This medication works by competitively binding to cholinergic receptors at the motor endplate, blocking the action of acetylcholine, and consequently inhibiting neuromuscular transmission.

Meanwhile, succinylcholine (or suxamethonium) is an ultra-short-acting muscle relaxant belonging to the class of depolarizing neuromuscular blocking agents, mainly used to facilitate tracheal intubation and muscle relaxation in surgical procedures.

Both mivacurium and succinylcholine are rapidly metabolized by enzymatic hydrolysis catalyzed by the enzyme pseudocholinesterase or butyrylcholinesterase (BChE) in plasma. However, a rare but potentially serious adverse effect is prolonged apnea after administration of these agents under general anesthesia. This risk is associated with defects in the BChE enzyme, which may be caused by mutations in the BCHE gene that encodes this enzyme. Generally, people with BChE deficiency do not show symptoms until they receive drugs such as mivacurium or succinylcholine.

If you have a family history of BChE deficiency or a family member who has experienced problems related to anesthesia, it is essential to inform your doctor before undergoing any procedure that requires anesthesia.

TRADE NAMES

  • Mivacron® (mivacurium)
  • Anectine® (succinylcholine)
  • Quelicin® (succinylcholine)

Genes analyzed

BCHE

Bibliography

Alvarellos ML, McDonagh EM, Patel S, et al. PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2015 Dec;25(12):622-30.

Trujillo R, West WP. Pseudocholinesterase Deficiency. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.

Wichmann S, Færk G, Bundgaard JR, Gätke MR. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene. Pharmacogenet Genomics. 2016 Jul;26(7):351-6.

Zhu GD, Dawson E, Huskey A, et al. Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine. Pharmgenomics Pers Med. 2020 Sep 30;13:405-414.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy